Given its role as a negative regulator of the WNT-pathway it is tempting to speculate SFRP1 expression to be increased in the stroma as a protective reaction in non-metastatic tumours against EMT induction, whereas in the absence of such an increase EMT can promote metastatic dissemination of tumour cells. Here, SFRP1 is linked to neoplasm.